Markets
ACA insurance
(Sherwood News)

Selling government-sponsored insurance is looking less lucrative. It’s about to get even messier.

Cuts to Medicaid and signs that ACA enrollees are becoming costlier are weighing on some insurers. Is Centene the canary in the coal mine?

Providing healthcare on behalf of the government might be becoming less lucrative than it used to be.

On Tuesday, Centene, the largest seller of Affordable Care Act plans, tanked after it withdrew its 2025 guidance because new data showed its ACA enrollees are using their benefits significantly more than expected, which threatens to eat into profits. The government pays insurers to cover ACA enrollees based on how sick they are assumed to be.

Centene is down by about 40% Wednesday, setting it up for its worst single day since it went public in 2001.

The ACA, which passed in 2010 and took effect in 2014, gave millions of Americans access to healthcare by expanding who is eligible for Medicaid. It also created a multibillion-dollar revenue stream for insurance companies. Some struggled to offer profitable plans, in some cases even dropping off the ACA marketplace, but the market eventually leveled and insurers like Centene wound up making up a majority of their business via the government.

The news from Centene also dragged down other insurers, including Oscar Health and Molina Healthcare. Oscar, a digital-first newcomer, does make some money from ACA plans, but not nearly as much as others. It’s also a retail favorite vulnerable to speculation.

Molina, on the other hand, is in a similar boat as Centene. Nearly all of its revenue comes from selling Medicare and Medicaid plans. The company fell 20% on Wednesday.

But sicker ACA enrollees may be just the start of their problems.

President Trump and his supporters in Congress have made it their mission to cut government spending on social programs, and Medicaid and Medicare are at the top of their list. Republicans are pushing a bill that would result in the largest cut to Medicaid in history, threatening to shrink a key revenue stream.

UnitedHealthcare, the insurance arm of the conglomerate United Health Group, is also down for the year, but not quite for the same reasons.

UNH, the largest health insurer in the country, gets a larger sum of its revenue from Medicare Advantage. The program allows American seniors to get their government-funded healthcare through a private insurer. UNH said in its most recent earnings report that its Medicare Advantage costs were higher than expected.

Higher costs are also not the company’s only issue. The head of its insurance arm, Brian Thompson, was killed in Manhattan in December in a high-profile shooting, with alleged gunman Luigi Mangione having expressed frustration with healthcare companies. UnitedHealth ousted its CEO in May amid increased government scrutiny over potential fraud in its Medicare Advantage program as well as antitrust probe. A whistleblower report by The Guardian set it back another notch.

UNH and its peers may not have an easy time winning over lawmakers and regulators, even if cutting their revenue streams means Americans, especially the poor and vulnerable, will die.

More Markets

See all Markets
Bull with Nose Ring

US stocks end volatile week on a positive note

The S&P 500 and Nasdaq 100 both ended well in the green, while the Russell 2000 suffered a loss.

markets

Margins, and selling the news: analysts look to explain Oracle’s tumble

The somewhat counterintuitive tumble in Oracle shares continued into afternoon trading Friday, despite Wall Street analysts’ more or less favorable reaction to Oracle’s investor day presentation Thursday, where executives said the company’s AI cloud business would eventually sport margins of between 30% and 40%, far better than the figures reported by The Information back on September 7.

And yet, the stock is on its way to its worst day in the last six months. What gives?

Gil Lauria, who covers Oracle for D.A. Davidson & Co. — who has it at “hold” with a $300 price target — has a theory, telling Sherwood News:

“Investors are disappointed that the entire growth acceleration in Oracle is from the Oracle Cloud Infrastructure business, and that Oracle expects the rest of the business to grow low single digits.

The other disappointment came from Oracle acknowledging that the GPU rental business only had 30-40% gross margins, far lower than the 80% gross margins for the rest of the business.”

Other analysts we’ve chatted with on background say they’re not convinced the margin story is the source of today’s slump, suggesting the also plausible explanation that the drop might just be a sign traders bought the stock ahead of the presentation to analysts on Thursday anticipating positive announcements, and now they’re selling simply selling the news.

Gil Lauria, who covers Oracle for D.A. Davidson & Co. — who has it at “hold” with a $300 price target — has a theory, telling Sherwood News:

“Investors are disappointed that the entire growth acceleration in Oracle is from the Oracle Cloud Infrastructure business, and that Oracle expects the rest of the business to grow low single digits.

The other disappointment came from Oracle acknowledging that the GPU rental business only had 30-40% gross margins, far lower than the 80% gross margins for the rest of the business.”

Other analysts we’ve chatted with on background say they’re not convinced the margin story is the source of today’s slump, suggesting the also plausible explanation that the drop might just be a sign traders bought the stock ahead of the presentation to analysts on Thursday anticipating positive announcements, and now they’re selling simply selling the news.

markets

Analysts generally like what they heard from Oracle, but shares are down

The big news out from the Oracle AI World conference was broadly positive: that margins on cloud infrastructure can be as high as 35%, and that the company predicts $166 billion in infrastructure revenue by 2030.

And in the wake of that news, today UBS raised its price target for Oracle shares to $380 from $360, saying they are undervalued.

But investors appear to have some concerns about Oracle’s huge capex plans, which are fueled by huge AI infrastructure deals with OpenAI and Meta, as shares dropped over 7% in Friday trading.

Analysts have pointed to Oracle’s high cash burn as it pursues its AI build-out and potential financing needs as flies in the ointment that could blunt the impact of the company’s strong longer-term growth forecasts.

On Friday, Jefferies analysts wrote:

“Questions remain about ORCL’s capex requirements to meet growing demand, as there was no forward-looking commentary on capex at the Analyst Day. Capex will need to ramp in line with [Oracle cloud infrastructure] revenue growth, raising concerns about ORCL’s financing options to support this expansion.”

However, if that’s the reason why the stock is getting hit today, it would mark a distinct change in how investors are evaluating the AI trade. Companies have tended to be increasingly rewarded for their aggressive capex commitments to enhance the boom, based on optimism that investments in this would-be revolutionary technology will bear fruit.

Friday’s dip comes on the back of a strong run leading up to the yesterday’s investor conference, fueled by a flurry of AI headlines. Oracle shares have gained over 18% in the past three months and more than 70% so far this year, well outpacing the Nasdaq’s approximately 7% and 16% rise over the same time periods.

markets

AST SpaceMobile drops after Barclays cuts rating to “underweight”

AST SpaceMobile, which provides cellular services from space, dove in early trading after Barclays analysts cut their rating on the shares to “underweight” (essentially a sell) from “overweight” (or a buy), citing “excessive” valuation on the still money-burning company. The fact that analysts went from “buy” to “sell” — with no momentary stop at a “hold” or “neutral” rating — makes it a fairly rare “double downgrade.”

They wrote:

“Valuation has run ahead of fundamentals... In our last update, we increased our price target from $38 to $60 as we took a more constructive view on pricing; we found it supportive that TMUS/Starlink launched a text only service for $10 per month and believe that AST products which will be richer (text, call, broadband) could see higher prices points. Since then the stock price has doubled from $48 to $95.7.”

With the shares up almost 120% over the last month through Thursday, and a price-to-forward-sales ratio of 140x — the Nasdaq Composite is around 5x — the stock might be due for a cooling-off period.

'There's nothing perfect in this world of growing apples.' Extreme weather could complicate future harvests.

The remarkable rise of the Honeycrisp and Cosmic Crisp apples

When it comes to apples, America cannot get enough of the crunch factor.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.